Showing 1 - 2 of 2 Research Library Publications
Posted: | D. Jurich, S.A. Santen, M. Paniagua, A. Fleming, V. Harnik, A. Pock, A. Swan-Sein, M.A. Barone, M. Daniel

Academic Medicine: Volume 95 - Issue 1 - p 111-121

 

This paper investigates the effect of a change in the United States Medical Licensing Examination Step 1 timing on Step 2 Clinical Knowledge (CK) scores, the effect of lag time on Step 2 CK performance, and the relationship of incoming Medical College Admission Test (MCAT) score to Step 2 CK performance pre and post change.

Posted: | M. C. Edwards, A. Slagle, J. D. Rubright, R. J. Wirth

Qual Life Res 27, 1711–1720 (2018)

 

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.